Cell Signaling Technology (CST) is a private,family-owned company, founded by scientists and dedicated to providing theworld's highest quality, innovative research and diagnostic products toaccelerate biological understanding and enable personalized medicine. Ouremployees operate worldwide from our U.S. headquarters in Massachusetts, andour offices in the Netherlands, China, and Japan.
Our Commitments Science
In addition to product development andproduction, CST is also actively engaged in the development of new technologiesfor signaling analysis as well as mechanistic cell biology research. CSTscientistspublishtheir findings in the highestquality peer-reviewed journals including: Nature Biotechnology, Cell, Journalof Immunology, and Journal of Biological Chemistry. Moreover, CST has built andcontinues to add functionality to our PhosphoSitePlus®bioinformatics resource (www.phosphosite.org),an NIH-funded, publicly accessible knowledge-base containing actively curatedinformation about known and CST-discovered regulatory post-translationalmodifications on proteins from human, mouse, and related species.